FIGS/$FIGS
1D1W1MYTD1Y5YMAX
Capital at risk
About FIGS
FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.
- Ticker
- $FIGS
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 359
- Headquarters
- Santa Monica, United States
- Website
- www.wearfigs.com
FIGS Metrics
BasicAdvanced
$2.3B
43.01
$0.33
1.02
-
Price and volume
Market cap
$2.3B
Beta
1.02
52-week high
$17.48
52-week low
$6.74
Average daily volume
2.6M
Financial strength
Current ratio
4.956
Quick ratio
3.497
Long term debt to equity
0.11
Total debt to equity
0.13
Profitability
EBITDA (TTM)
78.853
Gross margin (TTM)
68.91%
Net profit margin (TTM)
8.72%
Operating margin (TTM)
9.60%
Effective tax rate (TTM)
19.20%
Revenue per employee (TTM)
$1,980,000
Management effectiveness
Return on assets (TTM)
7.75%
Return on equity (TTM)
14.76%
Valuation
Price to earnings (TTM)
43.012
Price to revenue (TTM)
3.28
Price to book
5.28
Price to tangible book (TTM)
5.28
Price to free cash flow (TTM)
23.954
Free cash flow yield (TTM)
4.17%
Free cash flow per share (TTM)
0.588
Growth
Revenue change (TTM)
24.67%
Earnings per share change (TTM)
653.94%
3-year revenue growth (CAGR)
10.11%
3-year earnings per share growth (CAGR)
60.34%
What the Analysts think about FIGS
Analyst ratings (Buy, Hold, Sell) for FIGS stock.
Analyst projections of the future price of FIGS stock.
Bulls say / Bears say
Second-quarter revenue rose 28.8% and active customers grew 13.2%. FIGS raised its 2026 revenue-growth outlook to about 20%, from 14%–16%, signalling stronger near-term momentum. (The Motley Fool)
International revenue jumped 67% in the second quarter, and FIGS had expanded into 85 markets. Continued growth abroad offers a substantial path to broaden sales beyond its US base. (last10k.com, The Motley Fool)
FIGS is developing growth channels beyond individual online sales: it secured a Bupa Dental Care contract covering nearly 400 UK centres and planned four more Community Hub openings in the second half of 2026. (The Motley Fool)
The 820-basis-point rise in second-quarter gross margin was largely temporary: tariff refunds contributed 780 basis points. FIGS said its underlying full-year gross-margin outlook was only for modest improvement on 2025, so the headline margin may not last. (The Motley Fool)
A US import restriction blocks goods from a Jordanian supplier that made about one-third of second-quarter finished products. FIGS expects the disruption and its supply-chain adjustments to weigh on second-half results, including through added airfreight costs. (StockTitan)
FIGS traded at about 41 times earnings in an August assessment, versus roughly 21 times for its peer group. That premium leaves the shares exposed if growth or profitability falls short of expectations. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2026.
FIGS Financial Performance
Revenues and expenses
FIGS Earnings Performance
Company profitability
Upcoming events
No upcoming events
FIGS News
AllArticlesVideos
Funds containing FIGS
AllEURGBPUSD
Fund name | Fund size | $FIGS weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.05% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.05% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.